Abstract

The objective of this research was to prove whether miR-490-3p regulated the propagation, migration, and invasion of lung tumor cells using targeting sequence similarity as family 83F (FAM83F). The gene expression of miR-490-3p and FAM83F of human embryonic lung fibroblasts (HELF) and lung cancer cells (A549, H1299, 95D) were analyzed using real-time quantitative reverse transcription-polymerase chain reaction PCR (RT-qPCR) and western blot. Analysis of the targeted relationship of miR-490-3P with FAM83F was performed through double luciferase reporting assays with the addition of western blotting. The impacts of miR-490-3p and FAM83F gene expression were tested by cell counting kits (CCK-8), a scraping healing test, and a transwell test on the proliferation activity, scratch healing rate, and the numbers of migrating and invading A549 cells. Impacts of miR-490-3P and FAM83F expressions on the phosphorylated protein kinase B’ (p-AKT) expression were tested with western blotting. miR-490-3P gene expressions in A549 were observably less expressed compared to that of HELF cells, but the mRNA and protein expressions of FAM83F were observably greater than those in HELF (P < 0.05), which indicates that miR-490-3p-bound FAM83F regulates the expression of FAM83F immediately and negatively. After up-regulating miR-490-3p expression or down-regulating FAM83F expression, the proliferation activity, rate of wound-healing, the numbers of migrating and invading cells, and p-AKT protein expression of A549 cells were observably reduced (P < 0.05). Compared to upregulation of miR-490-3p, the propagation activity, wound-healing rate, numbers of migrating and invading cells, and expression of the P-Akt protein of A549 cells were significantly decreased after the upregulation of miR-490-3p and FAM83F (P < 0.05). MiR-490-3p observably inhibited migration and invasion in lung cancer cells with negatively regulating expression of FAM83F, and the mechanisms might be relevant to restraining the AKT pathway.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call